134 related articles for article (PubMed ID: 29736922)
1. Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis.
Sitenga JL; Aird G; Ahmed A; Walters R; Silberstein PT
Int J Dermatol; 2018 Oct; 57(10):1149-1156. PubMed ID: 29736922
[TBL] [Abstract][Full Text] [Related]
2. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
[TBL] [Abstract][Full Text] [Related]
3. Education and insurance status: Impact on treatment and survival of sinonasal cancer patients.
Agarwal P; Jones EA; Devaiah AK
Laryngoscope; 2020 Mar; 130(3):649-658. PubMed ID: 31165512
[TBL] [Abstract][Full Text] [Related]
4. The Odds of Stage IV Melanoma Diagnoses Based on Socioeconomic Factors.
Dick M; Aurit S; Silberstein P
J Cutan Med Surg; 2019; 23(4):421-427. PubMed ID: 31081374
[TBL] [Abstract][Full Text] [Related]
5. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
6. Melanoma in situ and invasive melanoma of the vulva: An analysis of the National Cancer Database.
Behbahani S; Malerba S; Warren CJ; Pomeranz MK; Samie FH
J Am Acad Dermatol; 2021 Jun; 84(6):1744-1749. PubMed ID: 32950551
[No Abstract] [Full Text] [Related]
7. Disparities in melanoma presentation and overall survival among disaggregated Hispanic nationalities: A retrospective analysis of 2,517 patients in the National Cancer Database.
Kim DY; Behbahani S; Moncayo A; Trepanowski N; Hartman RI
Arch Dermatol Res; 2024 Jun; 316(7):377. PubMed ID: 38850418
[No Abstract] [Full Text] [Related]
8. The impact of demographics, socioeconomics, and health care access on melanoma outcomes.
Cortez JL; Vasquez J; Wei ML
J Am Acad Dermatol; 2021 Jun; 84(6):1677-1683. PubMed ID: 32783908
[TBL] [Abstract][Full Text] [Related]
9. Using SEER data to quantify effects of low income neighborhoods on cause specific survival of skin melanoma.
Cheung MR
Asian Pac J Cancer Prev; 2013; 14(5):3219-21. PubMed ID: 23803107
[TBL] [Abstract][Full Text] [Related]
10. Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States.
Abudu B; Cook KA; Gershenwald JE; Cohen PR; Geller AC
Cancer; 2020 Feb; 126(4):775-781. PubMed ID: 31714593
[TBL] [Abstract][Full Text] [Related]
11. Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma.
Kakish H; Pawar O; Bhatty M; Doh S; Mulligan KM; Rothermel LD; Bordeaux JS; Mangla A; Hoehn RS
Am J Clin Oncol; 2024 May; 47(5):239-245. PubMed ID: 38251734
[TBL] [Abstract][Full Text] [Related]
12. Macroeconomic environment and insurance-mortality relationship: An analysis of gender-based disparity among non-elderly adult patients of melanoma and lung cancer.
Adnan H; Adnan SM; Deng K; Yang C; Hou Y; Ngo Nkondjock VR; Li K
Eur J Cancer Care (Engl); 2020 Jul; 29(4):e13229. PubMed ID: 32011788
[TBL] [Abstract][Full Text] [Related]
13. Effects of socioeconomic status on children with well-differentiated thyroid cancer.
Garner EF; Maizlin II; Dellinger MB; Gow KW; Goldfarb M; Goldin AB; Doski JJ; Langer M; Nuchtern JG; Vasudevan SA; Raval MV; Beierle EA
Surgery; 2017 Sep; 162(3):662-669. PubMed ID: 28602495
[TBL] [Abstract][Full Text] [Related]
14. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
Zell JA; Cinar P; Mobasher M; Ziogas A; Meyskens FL; Anton-Culver H
J Clin Oncol; 2008 Jan; 26(1):66-75. PubMed ID: 18165642
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, treatment, and survival of invasive malignant melanoma (MM) in giant pigmented nevi (GPN) in adults: 976 cases from the National Cancer Data Base (NCDB).
Turkeltaub AE; Pezzi TA; Pezzi CM; Dao H
J Am Acad Dermatol; 2016 Jun; 74(6):1128-34. PubMed ID: 26899200
[TBL] [Abstract][Full Text] [Related]
16. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
[TBL] [Abstract][Full Text] [Related]
17. Outcomes and predictors of survival in cutaneous melanoma of the eyelid: An analysis of the National Cancer Database.
Behbahani S; Malerba S; Maniar A; Taback B; Troob SH; Marr BP; Samie FH
J Am Acad Dermatol; 2021 Jun; 84(6):1753-1758. PubMed ID: 33144152
[No Abstract] [Full Text] [Related]
18. Disparities of Immunotherapy Utilization in Patients with Stage III Cutaneous Melanoma: A National Perspective.
Al-Qurayshi Z; Crowther JE; Hamner JB; Ducoin C; Killackey MT; Kandil E
Anticancer Res; 2018 May; 38(5):2897-2901. PubMed ID: 29715114
[TBL] [Abstract][Full Text] [Related]
19. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
20. Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Immunother; 2019; 42(6):228-235. PubMed ID: 30985445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
